From 26 May 2022, clinical trials with in-vitro diagnostic products (IVDs) will be regulated by the Ordinance on Clinical Trials with Medical Devices (ClinO-MD) and no longer by the Clinical Trials Ordinance (ClinO).
If you are conducting or planning to conduct a trial with IVDs, please find more information here.
Updated on the 27.05.2022
The EU Clinical Trial Regulation (EU-CTR) will apply to clinical trials on medicinal products in the EU/EEA from 31 January 2022. The ClinO will continue to apply unchanged in Switzerland.
You can find further information regarding the EU-CTR on the website of the Federal Office of Public Health (FOPH).